Parallel Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Sell |
|
|||||
|
2025
Q1 | $618K | Sell |
|
|||||
|
2024
Q4 | $786K | Sell |
|
|||||
|
2024
Q3 | $1.39M | Buy |
|
|||||
|
2024
Q2 | $1.32M | Buy |
|
|||||
|
2024
Q1 | $1.11M | Buy |
|
|||||
|
2023
Q4 | $865K | Sell |
|
|||||
|
2023
Q3 | $1.33M | Buy |
|
|||||
|
2023
Q2 | $1.11M | Sell |
|
|||||
|
2023
Q1 | $1.27M | Sell |
|
|||||
|
2022
Q4 | $1.16M | Sell |
|
|||||
|
2022
Q3 | $1.18M | Sell |
|
|||||
|
2022
Q2 | $1.09M | Buy |
|
|||||
|
2022
Q1 | $730K | Sell |
|
|||||
|
2021
Q4 | $698K | Buy |
|
|||||
|
2021
Q3 | $631K | Buy |
|
|||||
|
2021
Q2 | $336K | Buy |
|
|||||
|
2021
Q1 | $238K | Sell |
|
|||||
|
2020
Q4 | $337K | Sell |
|
|||||
|
2020
Q3 | $499K | Buy |
|
|||||
|
2020
Q2 | $408K | Buy |
|
|||||
|
2020
Q1 | $270K | Buy |
|
|||||
|
2019
Q4 | $132K | Buy |
|
|||||
|
2019
Q3 | $77K | Sell |
|
|||||
|
2019
Q2 | $103K | Sell |
|
|||||
|
2019
Q1 | $162K | Buy |
|
|||||
|
2018
Q4 | $138K | Sell |
|
|||||
|
2018
Q3 | $189K | Buy |
|
|||||
|
2018
Q2 | $140K | Sell |
|
|||||
|
2018
Q1 | $159K | Sell |
|
|||||
|
2017
Q4 | $188K | Sell |
|
|||||
|
2017
Q3 | $246K | Sell |
|
|||||
|
2017
Q2 | $320K | Sell |
|
|||||
|
2017
Q1 | $442K | Buy |
|
|||||
|
2016
Q4 | $377K | Buy |
|